Despite tremendous efforts, only imiquimod (Aldara), a TLR7 agonist, has been approved by US FDA for treatment of papillomavirus-induced genital warts and basal cell carcinoma via topical use [36]. The gene discussed is TLR7; the disease is anogenital human papillomavirus infection.